Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
10.3390/jfb14080408 2 AgarwalA.KasinathanA.GanesanR.BalasubramanianA.BhaskaranJ.SureshS.et al (2018)
J Hypertension
"But, next-generation drugs that offer improved efficacy are under development and Lexaria is intent to establish DehydraTECH's benefits in these drugs that have not yet reached the marketplace." This is a large Study that will investigate 18 different study arms to evaluate new and novel DehydraTECH compositions
What the study does provide is a clinical signal that aligns with the mechanistic story
We obtained ED 50 and T 1/2 values from the best-fitting result among 10 iterations of simulation
US$ 29.76
US$ 24.18
US$ 29.47
US$ 25.51
